Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

South Korea · Delayed Price · Currency is KRW

87,100

+2,800 (3.32%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
BNF Business			31.72B	30.73B	26.65B	24.28B	17.78B
BNF Business Growth			3.24%	15.28%	9.76%	36.56%	5.42%
New Drug Business			-	-	-	4.35B	138.10M
New Drug Business Growth			-	-	-	3050.15%	246.47%
Total			31.72B	30.73B	26.65B	28.63B	17.92B
Total Growth			3.24%	15.28%	-6.92%	59.79%	-6.11%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			31.72B	30.73B	26.65B	24.28B	17.78B
South Korea Growth			3.24%	15.28%	9.76%	36.56%	-6.64%
Russia			-	-	-	128.05M	138.10M
Russia Growth			-	-	-	-7.27%	246.47%
Hong Kong			-	-	-	4.22B	-
Total			31.72B	30.73B	26.65B	28.63B	17.92B
Total Growth			3.24%	15.28%	-6.92%	59.79%	-6.11%

Source: S&P Global Market Intelligence.